Taking Control Of Your Diabetes (TCOYD)

⭐ Meet the Expert Lineup at ONE 2025! ONE 2025 is bringing together an incredible lineup of T1D experts, healthcare professionals, and industry leaders—all ready to share the latest advancements in diabetes care, cutting-edge research, and real-world strategies to help you thrive. This year’s speaker lineup features returning favorites you know and love, plus brand-new experts making their ONE 2025 debut. From game-changing technology and breakthrough treatments to nutrition, mental health, and everyday diabetes management, our speakers are leading voices in the T1D space—and many of them live with type 1 diabetes themselves. This isn’t just a conference—it’s a chance to learn, connect, and gain real, actionable insights from the best in the field. Join us and our amazing speakers at ONE 2025 for the ultimate T1D experience that you don't want to miss! Check out:https://bit.ly/3CZc8hv

⭐ Meet Madi Cheever: The T1D Dietitian You Need to Know at ONE 2025! When it comes to navigating food, blood sugar, and real-life diabetes management, Madi Cheever is redefining what’s possible. As a registered dietitian, diabetes coach, and founder of Type One Type Fun, Madi believes that diabetes care should be as unique as the person living with it—not a one-size-fits-all plan. At ONE 2025, Madi will be answering your biggest nutrition and meal planning questions in her session, "What to Eat? Ask the Type 1 Dietitian!" Whether it's balancing blood sugars, meal timing, or breaking free from rigid food rules, she’s all about helping people with T1D take control of their health without putting life on hold. Madi also shares real, practical strategies on her social media, where she creates educational videos, success stories, and tips that help people ditch the fear-based thinking and build a diabetes plan that actually works for them. Join us and our amazing speakers at ONE 2025 for the ultimate T1D experience that you don't want to miss! Learn more about ONE 2025 here: https://bit.ly/3CZc8hv

⭐ Meet Dr. David Ahn: Your Go-To Expert for Diabetes Tech at ONE 2025 If you're looking to level up your diabetes device game, Dr. David Ahn is the speaker you won’t want to miss at ONE 2025. As a diabetes technology expert and one of your returning favorites, Dr. Ahn, will be breaking down how to optimize your devices, troubleshoot common issues, and master AID systems, whether you're a beginner or an advanced user. Beyond the stage, Dr. Ahn is also dedicated to making diabetes tech easier to understand through his own social media page, where he shares informative videos on the latest advancements in diabetes devices, real-world troubleshooting tips, and practical insights to help you navigate diabetes tech with confidence. Join us and our amazing speakers at ONE 2025 for the ultimate T1D experience that you don't want to miss! Learn more here about ONE 2025 here: https://bit.ly/3CZc8hv

Ozempic or Mounjaro – Which One is Right for You? Both Ozempic and Mounjaro are powerful tools for managing type 2 diabetes, weight loss, and even heart and kidney health—but are they the same? Not quite! In our latest episode, Dr. Steve Edelman and Dr. Jeremy Pettus break down the key differences, from how they work in the body to real-world results in A1C reduction, weight loss, and beyond. Plus, they dive into the latest research on additional benefits, accessibility challenges, and what patients need to know when choosing between the two. Have you tried either of these medications? What was your experience like? Drop your thoughts in the comments! Curious about how they compare? We break it all down in our latest video: https://bit.ly/4j4h0RE

A New Kind of Diabetes Showdown is Coming to ADA Scientific Sessions at this year's FORUM 2025! TCOYD and The diaTribe Foundation are closing out ADA 2025 with something completely brand new—an interactive Jeopardy-style game show featuring some of the most well-known experts in diabetes care such as: Dr. Athena Philis-Tsimikas, MD, Dr. Juan Pablo Frias, Dr. Justin Gregory, & Dr. Leslie Eiland. This isn’t your ordinary panel discussion! Dr. Steve Edelman, Kelly Close, and our very own Alex Trebek, Dr. Jeremy Pettus, MD, will host a high-energy, fast-paced competition where top diabetes minds go head-to-head, tackling cutting-edge topics in treatments, technology, and clinical research. You’ll have the chance to engage, weigh in, and see how much you really know. Kick off the night with cocktails and networking, stay for coffee, desserts, and an insightful discussion with industry leading diabetes experts after the show! Discover how to join us and reserve your spot here: https://bit.ly/41ROjQY

TCOYD Stream Template

🚨 Dr. E & P's Top 5 Breakthroughs in Diabetes Research in 2025— NEW TCOYD Live Tomorrow! Imagine a world where T1D could be managed without insulin, artificial pancreas systems become the new standard, and gene therapies offer long-term solutions. These advancements aren’t just theories—they’re happening sooner than you think! Join Dr. Steve Edelman and Dr. Jeremy Pettus TOMORROW as they reveal the Top 5 Breakthroughs in Diabetes Care for 2025 in our next TCOYD LIVE March 27th at 10:30 AM PT. 🔔 Don’t miss out! Find out how you can join us and learn more here: https://bit.ly/42dEtKo

Mounjaro or Ozempic: Which One Is Right for You? Both Mounjaro and Ozempic are weekly injectables that help control blood sugar and support weight loss, but they work in slightly different ways. While Ozempic mimics GLP-1, Mounjaro activates both GLP-1 and GIP. With studies exploring even more health benefits, from heart and kidney protection to potential effects on metabolic conditions, how do you know which one is best for you? Have you or someone you know tried either of these medications? Let us know in the comments! Discover more about how they compare here: https://bit.ly/4bKUBXf

✈️Our docs have landed in Amsterdam, and they’re diving into the future of diabetes care at ATTD otherwise known as the Advanced Technologies & Treatments for Diabetes (ATTD)! -Dr. Edelman is gearing up for an engaging debate on continuous ketone monitoring. We’re excited to hear the latest insights! - Dr. Pettus is stepping up to the mic at a major symposium on screening for type 1 diabetes, spreading the word on why catching T1D early is a game-changer. They’re soaking up all the latest advancements in diabetes treatment and tech, and we can’t wait to share the biggest takeaways when they’re back! What are you hoping to hear about from ATTD? Drop your thoughts below! #ATTD2025

CGM for Patients Living With Type 2 Diabetes? Let Us Tell You Why It’s a Game Changer! CGMs were once only prescribed for type 1 diabetes, but research now shows their benefits for type 2 diabetes are undeniable. With over 500 clinical studies, CGM use in T2D has been linked to lower A1C, increased time in range, reduced hypoglycemia, and improved lifestyle decisions around diet and exercise. Dr. E explains these benefits and more in our full video! Are you or your patients using CGM for type 2 diabetes? What changes have you noticed? Share your thoughts in the comments. Dexcom Watch the full video to learn more here: https://bit.ly/4bRP2q5